XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Jan. 03, 2025
Dec. 29, 2023
Dec. 30, 2022
Dec. 31, 2021
Jan. 01, 2021
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table

PAY VERSUS PERFORMANCE DISCLOSURE

The following table provides information on compensation for the principal executive officer (“PEO”), the average compensation for the other Named Executive Officers (“Non-PEO NEOs”) and certain measures of the Company’s financial performance for the last five fiscal years ended January 3, 2025:
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of Initial Fixed $100 Investment Based on:

 

 

 

 

 

 

 

Year

 

Summary Compensation Table Total for PEO ($)(1)

 

 

Compensation Actually Paid to PEO ($)(1)

 

 

Average Summary Compensation Table Total for Non-PEO NEOs ($)(1)

 

 

Average Compensation Actually Paid to Non-PEO NEOs ($)(1)

 

 

Total Shareholder Return
(2)

 

 

Peer Group Total Shareholder Return
(3)

 

 

Net Income
($ '000)
(4)

 

 

EBITDA
($ '000)
(5)

 

2024

 

 

3,495,068

 

 

 

3,468,736

 

 

 

1,908,925

 

 

 

1,922,398

 

 

 

133

 

 

 

166

 

 

 

109,002

 

 

 

147,058

 

2023

 

 

3,558,964

 

 

 

2,829,817

 

 

 

1,885,140

 

 

 

1,683,408

 

 

 

130

 

 

 

144

 

 

 

100,339

 

 

 

137,662

 

2022

 

 

3,589,062

 

 

 

2,322,702

 

 

 

1,626,994

 

 

 

1,245,805

 

 

 

145

 

 

 

124

 

 

 

102,330

 

 

 

137,217

 

2021

 

 

3,022,417

 

 

 

5,151,590

 

 

 

1,500,913

 

 

 

2,165,705

 

 

 

169

 

 

 

142

 

 

 

101,202

 

 

 

132,258

 

2020

 

 

2,674,793

 

 

 

4,300,765

 

 

 

1,362,236

 

 

 

1,938,548

 

 

 

129

 

 

 

114

 

 

 

82,552

 

 

 

102,102

 

 

(1)
Dr. Corrigan was the PEO in 2024, 2023, 2022, 2021 and 2020. Mr. Schlenker, Dr. Rakow Dr. Reitman and Dr. Sala were the non-PEO NEOs in 2024. Mr. Schlenker, Dr. Guyer, Dr. Rakow and Dr. Reitman were the non-PEO NEOs in 2023. Mr. Schlenker, Dr. Murray, Dr. Reitman and Dr. Pye were the non-PEO NEOs in 2022. Mr. Schlenker, Dr. Murray, Dr. Reitman and Dr. Doyle were the non-PEO NEOs in 2021. Mr. Schlenker, Dr. Murray, Dr. Reitman and Dr. James were the non-PEO NEOs in 2020.The value of the “compensation actually paid” to our PEO and Non-PEO NEOs reflect the following adjustments from the Summary Compensation Table:

 

Compensation Actually Paid
Adjustment Summary

 

Principal Executive Officer ($)(PEO)

 

 

Non PEO Named Executive Officers ($)(NEO)
(average)

 

 

 

2024

 

 

2024

 

Summary Compensation Table (SCT) Total

 

 

3,495,068

 

 

 

1,908,925

 

Stock and option award values reported in the SCT

 

 

(1,640,626

)

 

 

(773,438

)

The year-end fair value of any outstanding and unvested stock awards granted during the year

 

 

539,061

 

 

 

370,666

 

The year-end fair value of any outstanding and unvested option awards granted during the year

 

 

859,803

 

 

 

143,300

 

The change in fair value as of the vesting date (from the end of the prior year) of any stock awards that vest during the year

 

 

(57,396

)

 

 

(26,649

)

The change in fair value as of the vesting date (from the end of the prior year) of any option awards that vest during the year

 

 

(140,548

)

 

 

(23,425

)

The change in year-end fair value (from the end of the prior year) of any outstanding and unvested stock awards granted in prior years

 

 

14,270

 

 

 

6,443

 

The change in year-end fair value (from the end of the prior year) of any outstanding and unvested option awards granted in prior years

 

 

(80,904

)

 

 

(13,484

)

'The dollar value of stock awards that were both granted and vested during the year

 

 

480,008

 

 

 

330,060

 

The dollar value of any dividends or other earnings paid on stock or option awards during the year (prior to vesting) that are not otherwise reflected

 

 

 

 

 

 

Compensation Actually Paid

 

 

3,468,736

 

 

 

1,922,398

 

 

(2)
Amounts represent the cumulative Total Shareholder Return ("TSR") for Exponent calculated and presented as the dollar value of an investment of $100 made on January 3, 2020, assuming dividend reinvestment.
(3)
Amounts represent the cumulative TSR for the S&P 400 Mid Cap Index as "Peer Group" calculated and presented as the dollar value of an investment of $100 made on January 3, 2020, assuming dividend reinvestment.
(4)
Net Income is calculated in accordance with generally accepted accounting principles.
(5)
EBITDA is our company-selected measure and is defined as net income before income taxes, interest income, depreciation and amortization.
       
Company Selected Measure Name EBITDA        
Named Executive Officers, Footnote Dr. Corrigan was the PEO in 2024, 2023, 2022, 2021 and 2020. Mr. Schlenker, Dr. Rakow Dr. Reitman and Dr. Sala were the non-PEO NEOs in 2024. Mr. Schlenker, Dr. Guyer, Dr. Rakow and Dr. Reitman were the non-PEO NEOs in 2023. Mr. Schlenker, Dr. Murray, Dr. Reitman and Dr. Pye were the non-PEO NEOs in 2022. Mr. Schlenker, Dr. Murray, Dr. Reitman and Dr. Doyle were the non-PEO NEOs in 2021. Mr. Schlenker, Dr. Murray, Dr. Reitman and Dr. James were the non-PEO NEOs in 2020.        
Peer Group Issuers, Footnote Amounts represent the cumulative TSR for the S&P 400 Mid Cap Index as "Peer Group" calculated and presented as the dollar value of an investment of $100 made on January 3, 2020, assuming dividend reinvestment.        
PEO Total Compensation Amount $ 3,495,068 $ 3,558,964 $ 3,589,062 $ 3,022,417 $ 2,674,793
PEO Actually Paid Compensation Amount $ 3,468,736 2,829,817 2,322,702 5,151,590 4,300,765
Adjustment To PEO Compensation, Footnote

Compensation Actually Paid
Adjustment Summary

 

Principal Executive Officer ($)(PEO)

 

 

Non PEO Named Executive Officers ($)(NEO)
(average)

 

 

 

2024

 

 

2024

 

Summary Compensation Table (SCT) Total

 

 

3,495,068

 

 

 

1,908,925

 

Stock and option award values reported in the SCT

 

 

(1,640,626

)

 

 

(773,438

)

The year-end fair value of any outstanding and unvested stock awards granted during the year

 

 

539,061

 

 

 

370,666

 

The year-end fair value of any outstanding and unvested option awards granted during the year

 

 

859,803

 

 

 

143,300

 

The change in fair value as of the vesting date (from the end of the prior year) of any stock awards that vest during the year

 

 

(57,396

)

 

 

(26,649

)

The change in fair value as of the vesting date (from the end of the prior year) of any option awards that vest during the year

 

 

(140,548

)

 

 

(23,425

)

The change in year-end fair value (from the end of the prior year) of any outstanding and unvested stock awards granted in prior years

 

 

14,270

 

 

 

6,443

 

The change in year-end fair value (from the end of the prior year) of any outstanding and unvested option awards granted in prior years

 

 

(80,904

)

 

 

(13,484

)

'The dollar value of stock awards that were both granted and vested during the year

 

 

480,008

 

 

 

330,060

 

The dollar value of any dividends or other earnings paid on stock or option awards during the year (prior to vesting) that are not otherwise reflected

 

 

 

 

 

 

Compensation Actually Paid

 

 

3,468,736

 

 

 

1,922,398

 

       
Non-PEO NEO Average Total Compensation Amount $ 1,908,925 1,885,140 1,626,994 1,500,913 1,362,236
Non-PEO NEO Average Compensation Actually Paid Amount $ 1,922,398 1,683,408 1,245,805 2,165,705 1,938,548
Adjustment to Non-PEO NEO Compensation Footnote

Compensation Actually Paid
Adjustment Summary

 

Principal Executive Officer ($)(PEO)

 

 

Non PEO Named Executive Officers ($)(NEO)
(average)

 

 

 

2024

 

 

2024

 

Summary Compensation Table (SCT) Total

 

 

3,495,068

 

 

 

1,908,925

 

Stock and option award values reported in the SCT

 

 

(1,640,626

)

 

 

(773,438

)

The year-end fair value of any outstanding and unvested stock awards granted during the year

 

 

539,061

 

 

 

370,666

 

The year-end fair value of any outstanding and unvested option awards granted during the year

 

 

859,803

 

 

 

143,300

 

The change in fair value as of the vesting date (from the end of the prior year) of any stock awards that vest during the year

 

 

(57,396

)

 

 

(26,649

)

The change in fair value as of the vesting date (from the end of the prior year) of any option awards that vest during the year

 

 

(140,548

)

 

 

(23,425

)

The change in year-end fair value (from the end of the prior year) of any outstanding and unvested stock awards granted in prior years

 

 

14,270

 

 

 

6,443

 

The change in year-end fair value (from the end of the prior year) of any outstanding and unvested option awards granted in prior years

 

 

(80,904

)

 

 

(13,484

)

'The dollar value of stock awards that were both granted and vested during the year

 

 

480,008

 

 

 

330,060

 

The dollar value of any dividends or other earnings paid on stock or option awards during the year (prior to vesting) that are not otherwise reflected

 

 

 

 

 

 

Compensation Actually Paid

 

 

3,468,736

 

 

 

1,922,398

 

       
Compensation Actually Paid vs. Net Income

img39747903_3.jpg

       
Compensation Actually Paid vs. Company Selected Measure

img39747903_4.jpg

       
Total Shareholder Return Vs Peer Group

img39747903_2.jpg

       
Tabular List, Table

Performance Measures. The following table lists the most important financial performance measures used to link CAP to the PEO and Non-PEO NEOs for the fiscal year ended January 3, 2025:

EBITDA

Revenues before reimbursement growth

EBITDA margin

       
Total Shareholder Return Amount $ 133 130 145 169 129
Peer Group Total Shareholder Return Amount 166 144 124 142 114
Net Income (Loss) $ 109,002,000 $ 100,339,000 $ 102,330,000 $ 101,202,000 $ 82,552,000
Company Selected Measure Amount 147,058,000 137,662,000 137,217,000 132,258,000 102,102,000
PEO Name Dr. Corrigan Dr. Corrigan Dr. Corrigan Dr. Corrigan Dr. Corrigan
Measure:: 1          
Pay vs Performance Disclosure          
Name EBITDA        
Non-GAAP Measure Description EBITDA is our company-selected measure and is defined as net income before income taxes, interest income, depreciation and amortization.        
Measure:: 2          
Pay vs Performance Disclosure          
Name Revenues before reimbursement growth        
Measure:: 3          
Pay vs Performance Disclosure          
Name EBITDA margin        
PEO | Stock and option award values reported in the SCT [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (1,640,626)        
PEO | Year-end Fair Value Of Any Outstanding And Unvested Stock Awards Granted During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 539,061        
PEO | Year-end Fair Value Of Any Outstanding And Unvested Option Awards Granted During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 859,803        
PEO | Change In Fair Value As Of The Vesting Date (From The End Of The Prior Year) Of Any Stock Awards That Vest During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (57,396)        
PEO | Change In Fair Value As Of The Vesting Date (From The End Of The Prior Year) Of Any Option Awards That Vest During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (140,548)        
PEO | Change In Year-end Fair Value (From The End Of The Prior Year) Of Any Outstanding And Unvested Stock Awards Granted In Prior Years [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 14,270        
PEO | Change In Year-end Fair Value (From The End Of The Prior Year) Of Any Outstanding And Unvested Option Awards Granted In Prior Years [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (80,904)        
PEO | Dollar Value Of Stock Awards That Were Both Granted And Vested During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 480,008        
Non-PEO NEO | Stock and option award values reported in the SCT [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (773,438)        
Non-PEO NEO | Year-end Fair Value Of Any Outstanding And Unvested Stock Awards Granted During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 370,666        
Non-PEO NEO | Year-end Fair Value Of Any Outstanding And Unvested Option Awards Granted During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 143,300        
Non-PEO NEO | Change In Fair Value As Of The Vesting Date (From The End Of The Prior Year) Of Any Stock Awards That Vest During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (26,649)        
Non-PEO NEO | Change In Fair Value As Of The Vesting Date (From The End Of The Prior Year) Of Any Option Awards That Vest During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (23,425)        
Non-PEO NEO | Change In Year-end Fair Value (From The End Of The Prior Year) Of Any Outstanding And Unvested Stock Awards Granted In Prior Years [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 6,443        
Non-PEO NEO | Change In Year-end Fair Value (From The End Of The Prior Year) Of Any Outstanding And Unvested Option Awards Granted In Prior Years [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (13,484)        
Non-PEO NEO | Dollar Value Of Stock Awards That Were Both Granted And Vested During The Year [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 330,060